Ursprung des Netzwerks ersten Grades von Alexander Brown
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Convergent Therapeutics, Inc.
 Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Alexander Brown
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| DNIB UNWIND INC | Biotechnology | Corporate Officer/Principal | |
| Brown University | College/University | Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Comptroller/Controller/Auditor | |
| Bentley University | College/University | Undergraduate Degree | |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
| Prostate Cancer Foundation | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
| CHIMERIC THERAPEUTICS LIMITED | Biotechnology | Director/Board Member | |
| CONTEXT THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Xenimmune Therapeutics, Inc.
 Xenimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xenimmune Therapeutics, Inc. develops antibody-enzyme fusion to target tumors and trigger the hyper-acute rejection. The private company is located in the US. | Pharmaceuticals: Major | Founder |
Statistik
International
| Vereinigte Staaten | 17 |
| Kanada | 2 |
| Australien | 2 |
Sektoral
| Health Technology | 10 |
| Consumer Services | 5 |
| Health Services | 4 |
| Government | 2 |
| Miscellaneous | 2 |
Operativ
| Corporate Officer/Principal | 10 |
| Director/Board Member | 5 |
| Independent Dir/Board Member | 3 |
| Founder | 3 |
| Director of Finance/CFO | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Philip Kantoff | 11 |
| Eric Sullivan | 7 |
| Neil Bander | 3 |
- Börse
- Insiders
- Alexander Brown
- Unternehmensverbindungen
